Reprogramming of human somatic cells to pluripotency with defined factors View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2007-12-23

AUTHORS

In-Hyun Park, Rui Zhao, Jason A. West, Akiko Yabuuchi, Hongguang Huo, Tan A. Ince, Paul H. Lerou, M. William Lensch, George Q. Daley

ABSTRACT

Pluripotency pertains to the cells of early embryos that can generate all of the tissues in the organism. Embryonic stem cells are embryo-derived cell lines that retain pluripotency and represent invaluable tools for research into the mechanisms of tissue formation. Recently, murine fibroblasts have been reprogrammed directly to pluripotency by ectopic expression of four transcription factors (Oct4, Sox2, Klf4 and Myc) to yield induced pluripotent stem (iPS) cells. Using these same factors, we have derived iPS cells from fetal, neonatal and adult human primary cells, including dermal fibroblasts isolated from a skin biopsy of a healthy research subject. Human iPS cells resemble embryonic stem cells in morphology and gene expression and in the capacity to form teratomas in immune-deficient mice. These data demonstrate that defined factors can reprogramme human cells to pluripotency, and establish a method whereby patient-specific cells might be established in culture. More... »

PAGES

141-146

Journal

TITLE

Nature

ISSUE

7175

VOLUME

451

Related Patents

  • Methods For Tissue Generation
  • Induced Pluripotent Stem Cells With Synthetic Modified Rnas
  • Methods For Expanding And Maintaining Human Pluripotent Stem Cells (Pscs) In An Undifferentiated State In A Single Cell Suspension Culture
  • Pluripotent Cell Lines And Methods Of Use Thereof
  • Nuclear Reprogramming Factor Comprising Mirna And A Protein Factor
  • Modified Polynucleotides For Treating Galactosylceramidase Protein Deficiency
  • Cell Culture Platform For Single Cell Sorting And Enhanced Reprogramming Of Ipscs
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Methods Of Promoting Lymphangiogenesis
  • A Non-Viral System For The Generation Of Induced Pluripotent Stem (Ips) Cells
  • Induced Pluripotent Stem Cells Produced With Oct3/4, Klf4 And Sox2
  • Engineered Nucleic Acids Encoding A Modified Erythropoietin And Their Expression
  • Method For Production Of Reprogrammed Cell Using Chromosomally Unintegrated Virus Vector
  • Methods For Producing Hormone Secreting Cells In A Subject
  • Method For Modulating Myelination
  • Method To Direct Differentiation Of Pluripotent Stem Cells Into Functional Heart Muscle
  • Large Scale Production Of Retinal Pigment Epithelial Cells
  • Reprogramming Of Somatic Cells
  • Reprogramming Of Somatic Cells
  • New Serum-Free Medium For Inducing Pluripotent Stem Cells Quickly With High Efficiency And Method Using Thereof
  • Pluripotent Cell Lines And Methods Of Use Thereof
  • Kit For Making Induced Pluripotent Stem Cells Using Modified Rnas
  • Detection Of Human Somatic Cell Reprogramming
  • Use Of Cellular Extracts For Obtaining Pluripotent Stem Cells
  • Protein-Induced Pluripotent Cell Technology And Uses Thereof
  • Method For Reprogramming Cells
  • Assay For Mutations In Stem Cells And Their Derivatives
  • Compositions And Methods For Generation Of Human Epithelial Stem Cells
  • Method For Producing Engineered Heart Muscle (Ehm)
  • Method For Production Of Reprogrammed Cell Using Chromosomally Unintegrated Virus Vector
  • Somatic Cell Reprogramming
  • Isolated Mammalian Somatic Cells Containing Modified Rna Encoding Oct4, Sox2, And Klf4
  • Modified Polynucleotides For The Production Of Biologics And Proteins Associated With Human Disease
  • Method For Producing Stem Cell Clones Suitable For Induction Of Differentiation Into Somatic Cells
  • Generation Of Induced Pluripotent Stem Cells From Cord Blood
  • Modified Polynucleotides Encoding Granulysin
  • Methods For Producing Enucleated Erythroid Cells Derived From Pluripotent Stem Cells
  • Modifying The Specificity Of Non-Coding Rna Molecules For Silencing Genes In Eukaryotic Cells
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Somatic Cell Reprogramming By Retroviral Vectors Encoding Oct3/4. Klf4, C-Myc And Sox2
  • Modified Polynucleotides Encoding Cited4
  • Modified Polynucleotides For The Production Of Nuclear Proteins
  • Reprogramming A Cell By Inducing A Pluripotent Gene Through Rna Interference
  • Cell Compositions Derived From Dedifferentiated Reprogrammed Cells
  • Composition For Inducing Pluripotent Stem Cell, And Use Thereof
  • Mathematical Image Analysis Based Cell Reprogramming With Applications For Epigenetic And Non-Epigenetic Base Induced Pluripotent Stem Cell Derivation
  • Methods For Production Of Platelets From Pluripotent Stem Cells And Compositions Thereof
  • Method Of Efficiently Establishing Induced Pluripotent Stem Cells
  • Populations Of Neural Progenitor Cells And Methods Of Producing And Using Same
  • Induction Of Pluripotent Cells
  • Combinational Use Of Mechanical Manipulation And Programin Derivatives To Increase Oct4, Sox2, Nanog Or C-Myc Expression In Fibroblasts
  • Induced Pluripotent Stem Cell Model Of Chronic Myeloid Leukemia Revealed Olfactomedin 4 As A Novel Therapeutic Target In Leukemia Stem Cells
  • A Protein-Induced Pluripotent Cell Technology Uses Thereof
  • Methods And Products For Dedifferentiation Of Cells
  • Differentiation Into Brown Adipocytes
  • Systems And Methods For Increasing Efficiency Of Genome Editing
  • Reprogrammation Of Eukaryotic Cells With Engineered Microvesicles
  • Generation Of Neural Stem Cells And Motor Neurons
  • Preparation Of Photoreceptors For The Treatment Of Retinal Diseases
  • Assembly Of Functionally Integrated Human Forebrain Spheroids And Methods Of Use Thereof
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Cardiosphere-Derived Cells And Exosomes Secreted By Such Cells In The Treatment Of Heart Failure With Preserved Ejection Fraction
  • Method For Preparing Induced Paraxial Mesoderm Progenitor (Ipam) Cells And Their Use
  • Novel Methods And Culture Media For Culturing Pluripotent Stem Cells
  • Detection Of Human Somatic Cell Reprogramming
  • Introducing Silencing Activity To Dysfunctional Rna Molecules And Modifying Their Specificity Against A Gene Of Interest
  • Formulation For Regeneration Of Bone, Cartilage, Teeth, And Periodontium And Treatment Of Tumors And Cysts
  • Preparation Of Retinal Pigment Epithelium Cells
  • Methods And Platforms For Drug Discovery Using Induced Pluripotent Stem Cells
  • Modulators Of Telomere Disease
  • Compositions, Kits, And Methods For Making Induced Pluripotent Stem Cells Using Synthetic Modified Rnas
  • Retinal Pigment Epithelium Cell Compositions
  • Generation Of Reprogrammed Pluripotent Cells
  • Ets2 And Mesp1 Generate Cardiac Progenitors From Fibroblasts
  • Exosomes And Micro-Ribonucleic Acids For Tissue Regeneration
  • Methods Of Generating Lineage-Specific Cells From Undifferentiated Human Pluripotent Stem Cells Cultured In A Single Cell Suspension Culture
  • Large Scale Production Of Retinal Pigment Epithelial Cells
  • Efficient Method For Nuclear Reprogramming
  • Use Of Cellular Extracts For Obtaining Pluripotent Stem Cells
  • Method For Preparing Induced Paraxial Mesoderm Progenitor (Ipam) Cells And Their Use
  • Somatic Cell Reprogramming
  • Delivery And Formulation Of Engineered Nucleic Acids
  • Downregulation Of Mir-7 For Promotion Of Beta Cell Differentiation And Insulin Production
  • Culture Media For Pluripotent Stem Cells
  • Methods And Products For Dedifferentiation Of Cells
  • Induction Of Pluripotent Cells
  • Human Pluripotent Stem Cells Induced From Undifferentiated Stem Cells Derived From A Human Postnatal Tissue
  • Modified Polynucleotides For Treating Protein Deficiency
  • Modified Polynucleotides Encoding Septin-4
  • Modified Polynucleotides Encoding Apoptosis Inducing Factor 1
  • Methods And Compositions For Maintaining Genomic Stability In Cultured Stem Cells
  • Kits Comprising Linear Dnas For Sustained Polypeptide Expression Using Synthetic, Modified Rnas
  • Isolated Mesenchymal Progenitor Cells And Extracellular Matrix Produced Thereby
  • Populations Of Hematopoietic Progenitors And Methods Of Enriching Stem Cells Therefor
  • Methods Of Generating Corneal Cells And Cell Populations Comprising Same
  • Early Developmental Genomic Assay For Characterizing Pluripotent Stem Cell Utility And Safety
  • Media For Culturing Pluripotent Stem Cells
  • Single Cells Pluripotent Stem Cells In A Suspension Culture
  • Method For Improving Efficiency Of Inducing Pluripotent Stem Cell
  • Method For Production Of Pluripotent Stem Cell
  • Modified Polynucleotides For The Production Of Proteins Associated With Human Disease
  • Methods For Telomere Length And Genomic Dna Quality Control Analysis In Pluripotent Stem Cells
  • Protein-Induced Pluripotent Cell Technology And Uses Thereof
  • Method For Inducing Cells To Less Mature State
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Modified Polynucleotides Encoding Basic Helix-Loop-Helix Family Member E41
  • Early Developmental Genomic Assay For Characterizing Pluripotent Stem Cell Utility And Safety
  • Polycistronic Vector For Human Induced Pluripotent Stem Cell Production
  • Culture Method Of Embryoid Bodies And/Or Neural Stem Cells Derived From Human Differentiated Cell-Derived Pluripotent Stem Cells
  • Method For Production Of Pluripotent Stem Cell
  • Hemangio Colony Forming Cells And Non-Engrafting Hemangio Cells
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Stem Cell Culture Medium And Method
  • Modified Polynucleotides For The Production Of Proteins
  • Sustained Polypeptide Expression From Synthetic, Modified Rnas And Uses Thereof
  • Production Of Reprogrammed Pluripotent Cells
  • Methods For The Production Of Ips Cells Using Epstein-Barr (Ebv)-Based Reprogramming Vectors
  • Stem Cells And Uses Thereof
  • In Vitro Differentiation Of Pluripotent Stem Cells To Pancreatic Endoderm Cells (Pec) And Endocrine Cells
  • Modified Polynucleotides Encoding Copper Metabolism (Murr1) Domain Containing 1
  • Compositions And Methods Of Altering Cholesterol Levels
  • Human Blood-Brain Endothelial Cells Derived From Pluripotent Stem Cells And Blood-Brain Barrier Model Thereof
  • Human Airway Stem Cells In Lung Epithelial Engineering
  • Optimized Methods For Generation Of Cardiac Stem Cells From Cardiac Tissue And Their Use In Cardiac Therapy
  • Method For Production Of Pluripotent Stem Cell
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Method For Preparing Induced Pluripotent Stem Cells And Culture Medium Used For Preparing Induced Pluripotent Stem Cells
  • Stem Cell Culture Medium And Method
  • Methods And Formulations For Orthopedic Cell Therapy
  • Maintenance Of Genomic Stability In Cultured Stem Cells
  • Genetically Modified Stem Cells
  • Fingerprint For Cell Identity And Pluripotency
  • Generation Of Induced Pluripotent Stem (Ips) Cells
  • Ets2 And Mesp1 Generate Cardiac Progenitors From Fibroblasts
  • Combinational Use Of Mechanical Manipulation And Programin Derivatives To Increase Oct4, Sox2, Or Nanog Expression In Fibroblasts
  • Generation Of Induced Pluripotent Stem (Ips) Cells
  • Delivery And Formulation Of Engineered Nucleic Acids
  • Cdc-Derived Exosomes For Treatment Of Ventricular Tachyarrythmias
  • Generation Of Neural Stem Cells
  • Polynucleotides Encoding Immune Modulating Polypeptides
  • Differentiated Cells Originating In Artificial Pluripotent Stem Cells
  • Bioartifical Lung
  • Reprogramming Of Somatic Cells With Purified Proteins
  • Methods For Measuring Therapeutic Effects Of Retinal Disease Therapies
  • Reprogramming T Cells And Hematopoietic Cells
  • Method For Producing Induced Pluripotent Stem Cells, Cardiomyocytes Or Precursor Cells Thereof
  • Materials And Methods For Generating Pluripotent Stem Cells
  • Nuclear Reprogramming Factor
  • Preparation Of Photoreceptors For The Treatment Of Retinal Diseases
  • Modified Polynucleotides For The Production Of G-Csf
  • Functional Genomics Assay For Characterizing Pluripotent Stem Cell Utility And Safety
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • In Vitro Model Of Spinal Muscular Atrophy
  • Modified Polynucleotides For The Production Of Oncology-Related Proteins And Peptides
  • Modified Polynucleotides Encoding Hepatitis A Virus Cellular Receptor 2
  • Populations Of Pancreatic Progenitor Cells And Methods Of Isolating And Using Same
  • Methods, Systems And Compositions Relating To Cell Conversion Via Protein-Induced In-Vivo Cell Reprogramming
  • Modified Polynucleotides Encoding Siah E3 Ubiquitin Protein Ligase 1
  • Generation Of Induced Pluripotent Stem (Ips) Cells
  • Dlin-Kc2-Dma Lipid Nanoparticle Delivery Of Modified Polynucleotides
  • Culture Method Of Embryoid Bodies And/Or Neural Stem Cells Derived From Human Differentiated Cell-Derived Pluripotent Stem Cells
  • Compositions For Mesoderm Derived Isl1+ Multipotent Cells (Imps), Epicardial Progenitor Cells (Epcs) And Multipotent C56c Cells (C56cs) And Methods Of Producing And Using Same
  • Induced Presomitic Mesoderm (Ipsm) Cells And Their Use
  • Insulin Producing Cells Derived From Pluripotent Stem Cells
  • Providing Ipscs To A Customer
  • Methods For Maturing Cardiomyocytes And Uses Thereof
  • Methods For The Production Of Ips Cells Using Non-Viral Approach
  • Cardiosphere-Derived Cells And Exosomes Secreted By Such Cells In The Treatment Of Muscular Dystrophy
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Cannabidiol-Containing Compositions And Uses Thereof
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Modified Polynucleotides For The Production Of Cosmetic Proteins And Peptides
  • Methods For The Production Of Ips Cells
  • Pluripotent Stem Cell-Derived 3d Retinal Tissue And Uses Thereof
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Terminally Modified Rna
  • In Vivo Production Of Proteins
  • Programming And Reprogramming Of Cells
  • Polynucleotides Encoding Low Density Lipoprotein Receptor
  • Low-Molecular-Compound For Improving Production, Maintenance And Proliferation Of Pluripotent Stem Cells, Composition Comprising The Same, And Culture Method
  • Hemangio-Colony Forming Cells
  • Myc Variants Improve Induced Pluripotent Stem Cell Generation Efficiency
  • Reprogramming Somatic Cells Using Retroviral Vectors Comprising Oct-4 And Sox2 Genes
  • Method For Preparing Induced Paraxial Mesoderm Progenitor (Ipam) Cells And Their Use
  • Detection Of Human Somatic Cell Reprogramming
  • Pericyte Progenitor Cells And Methods Of Generating And Using Same
  • Culture Method Of Embryoid Bodies And/Or Neural Stem Cells Derived From Human Differentiated Cell-Derived Pluripotent Stem Cells
  • A Method To Direct Differentiation Of Pluripotent Stem Cells Into Functional Heart Muscle
  • Modified Polynucleotides For The Production Of Secreted Proteins
  • Preparation Of Retinal Pigment Epithelium Cells
  • Stem Cells And Uses Thereof
  • Isolated Naive Pluripotent Stem Cells And Methods Of Generating Same
  • Methods For Production Of Platelets From Pluripotent Stem Cells And Compositions Thereof
  • Method For Inducing Pluripotency In Human Somatic Cells With Prdm14 Or Nfrkb
  • Modified Polynucleotides Encoding Aquaporin-5
  • Large Scale Generation Of Functional Megakaryocytes And Platelets From Human Embryonic Stem Cells Under Stromal-Free Conditions
  • Populations Of Hematopoietic Progenitors And Methods Of Enriching Stem Cells Therefor
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Large Scale Production Of Retinal Pigment Epithelial Cells
  • Oct3/4, Klf4, C-Myc And Sox2 Produce Induced Pluripotent Stem Cells
  • Autologous Mammalian Models Derived From Induced Pluripotent Stem Cells And Related Methods
  • Methods And Pharmaceutical Compositions For Expressing A Polynucleotide Of Interest In The Retinal Pigment Epithelium Of A Subject
  • Modified Polynucleotides For The Production Of Proteins
  • Modified Polynucleotides Encoding Aryl Hydrocarbon Receptor Nuclear Translocator
  • Differentially Methylated Regions Of Reprogrammed Induced Pluripotent Stem Cells, Method And Compositions Thereof
  • Functional Astrocytes And Cortical Neurons From Induced Pluripotent Stem Cells And Methods Of Use Thereof
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Methods For Making And Using Sinoatrial Node-Like Pacemaker Cardiomyocytes And Ventricular-Like Cardiomyocytes
  • Cell Compositions Derived From Dedifferentiated Reprogrammed Cells
  • Human Pluripotent Stem Cells Induced From Undifferentiated Stem Cells Derived From A Human Postnatal Tissue
  • Split Dose Administration
  • Ets2 And Mesp1 Generate Cardiac Progenitors From Fibroblasts
  • Cell Compositions Derived From Dedifferentiated Reprogrammed Cells
  • Method Of Efficiently Establishing Induced Pluripotent Stem Cells
  • Method Of Effecting De-Differentiation Of A Cell
  • Non-Human Mammal Model Of Human Degenerative Disorder, Uses Thereof, And Method Of Treating Human Degenerative Disorder
  • Multipotent Stem Cell Cultures
  • Modified Polynucleotides For The Production Of Biologics And Proteins Associated With Human Disease
  • Method For Producing A Protein Of Interest In A Primate
  • Automated System For The Cultivation And Differentiation Of Pluripotent Stem Cells
  • Modulators Of Telomere Disease
  • Epigenomic Induced Pluripotent Stem Cell Signatures
  • Low-Molecular-Compound For Improving Production, Maintenance And Proliferation Of Pluripotent Stem Cells, Composition Comprising The Same, And Culture Method
  • Functionalized Nanoparticles For Intracellular Delivery Of Biologically Active Molecules
  • Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof
  • Protein-Induced Pluripotent Cell Technology And Uses Thereof
  • Modified Polynucleotides For The Production Of Proteins Associated With Blood And Lymphatic Disorders
  • Method To Reduce Oncogenic Potential Of Induced Pluripotent Stem Cells From Aged Donors
  • Methods Of Treating Diseases Related To Mitochondrial Function
  • Methods For Differentiating And Purifying Pancreatic Endocrine Cells
  • Assembly Of Functionally Integrated Human Forebrain Spheroids And Methods Of Use Thereof
  • Compositions And Methods For Restoring Or Preventing Loss Of Vision Caused By Disease Or Traumatic Injury
  • Genetically Modified Stem Cells
  • Formulation And Delivery Of Plga Microspheres
  • Platform For The Induction And Maintenance Of Ground State Pluripotency
  • Transcription Factor Mediated Programming Towards Megakaryocytes
  • Method For Preparing Induced Paraxial Mesoderm Progenitor (Ipam) Cells And Their Use
  • Method For Production Of Reprogrammed Cell Using Chromosomally Unintegrated Virus Vector
  • Modified Polynucleotides For The Production Of Cytoplasmic And Cytoskeletal Proteins
  • Method For Rejuvenating Cells
  • Reprogramming Methods And Cell Culture Platforms
  • Large Scale Generation Of Functional Megakaryocytes And Platelets From Human Embryonic Stem Cells Under Stromal-Free Conditions
  • Modified Polynucleotides Encoding Aquaporin-5
  • Populations Of Hematopoietic Progenitors And Methods Of Enriching Stem Cells Therefor
  • Method For Inducing Pluripotency In Human Somatic Cells With Prdm14 Or Nfrkb
  • Engineered Nucleic Acids And Methods Of Use Thereof
  • Large Scale Production Of Retinal Pigment Epithelial Cells
  • Methods For Production Of Platelets From Pluripotent Stem Cells And Compositions Thereof
  • Pluripotent Cell Lines And Methods Of Use Thereof
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nature06534

    DOI

    http://dx.doi.org/10.1038/nature06534

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1011992920

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/18157115


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Genetics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Differentiation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Shape", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cells, Cultured", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Methylation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA-Binding Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Embryonic Stem Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Fetus", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Fibroblasts", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Gene Expression Profiling", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "HMGB Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Homeodomain Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Infant, Newborn", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kruppel-Like Factor 4", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kruppel-Like Transcription Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nanog Homeobox Protein", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Octamer Transcription Factor-3", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pluripotent Stem Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Promoter Regions, Genetic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Proto-Oncogene Proteins c-myc", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "SOXB1 Transcription Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Teratoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transcription Factors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transplantation, Heterologous", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Park", 
            "givenName": "In-Hyun", 
            "id": "sg:person.0633264666.40", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633264666.40"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhao", 
            "givenName": "Rui", 
            "id": "sg:person.0701400066.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701400066.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "West", 
            "givenName": "Jason A.", 
            "id": "sg:person.01300040514.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300040514.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yabuuchi", 
            "givenName": "Akiko", 
            "id": "sg:person.01165236266.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165236266.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Huo", 
            "givenName": "Hongguang", 
            "id": "sg:person.01206166374.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206166374.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology, Brigham and Women\u2019s Hospital, and", 
              "id": "http://www.grid.ac/institutes/grid.62560.37", 
              "name": [
                "Department of Pathology, Brigham and Women\u2019s Hospital, and"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ince", 
            "givenName": "Tan A.", 
            "id": "sg:person.01233401714.29", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233401714.29"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Newborn Medicine, Brigham & Women\u2019s Hospital and Children\u2019s Hospital Boston, Boston, Massachusetts 02115, USA", 
              "id": "http://www.grid.ac/institutes/grid.2515.3", 
              "name": [
                "Division of Newborn Medicine, Brigham & Women\u2019s Hospital and Children\u2019s Hospital Boston, Boston, Massachusetts 02115, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lerou", 
            "givenName": "Paul H.", 
            "id": "sg:person.01071737774.79", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071737774.79"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lensch", 
            "givenName": "M. William", 
            "id": "sg:person.01022207136.99", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022207136.99"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Division of Pediatric Hematology/Oncology, Children\u2019s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women\u2019s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA", 
                "Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Daley", 
            "givenName": "George Q.", 
            "id": "sg:person.01326207001.66", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326207001.66"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nature05934", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002347899", 
              "https://doi.org/10.1038/nature05934"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1335", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049953935", 
              "https://doi.org/10.1038/nbt1335"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature05944", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019109862", 
              "https://doi.org/10.1038/nature05944"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1310", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024578139", 
              "https://doi.org/10.1038/nbt1310"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1107-1211a", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003688019", 
              "https://doi.org/10.1038/nbt1107-1211a"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/22780", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021312708", 
              "https://doi.org/10.1038/22780"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1318", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033397919", 
              "https://doi.org/10.1038/nbt1318"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt788", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013128911", 
              "https://doi.org/10.1038/nbt788"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2007-12-23", 
        "datePublishedReg": "2007-12-23", 
        "description": "Pluripotency pertains to the cells of early embryos that can generate all of the tissues in the organism. Embryonic stem cells are embryo-derived cell lines that retain pluripotency and represent invaluable tools for research into the mechanisms of tissue formation. Recently, murine fibroblasts have been reprogrammed directly to pluripotency by ectopic expression of four transcription factors (Oct4, Sox2, Klf4 and Myc) to yield induced pluripotent stem (iPS) cells. Using these same factors, we have derived iPS cells from fetal, neonatal and adult human primary cells, including dermal fibroblasts isolated from a skin biopsy of a healthy research subject. Human iPS cells resemble embryonic stem cells in morphology and gene expression and in the capacity to form teratomas in immune-deficient mice. These data demonstrate that defined factors can reprogramme human cells to pluripotency, and establish a method whereby patient-specific cells might be established in culture.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nature06534", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "7175", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "451"
          }
        ], 
        "keywords": [
          "embryonic stem cells", 
          "stem cells", 
          "iPS cells", 
          "human somatic cells", 
          "induced pluripotent stem cells", 
          "human iPS cells", 
          "pluripotent stem cells", 
          "human primary cells", 
          "patient-specific cells", 
          "early embryos", 
          "transcription factors", 
          "somatic cells", 
          "ectopic expression", 
          "pluripotency", 
          "gene expression", 
          "human cells", 
          "murine fibroblasts", 
          "defined factors", 
          "primary cells", 
          "cell lines", 
          "dermal fibroblasts", 
          "cells", 
          "invaluable tool", 
          "fibroblasts", 
          "expression", 
          "tissue formation", 
          "immune-deficient mice", 
          "healthy research subjects", 
          "organisms", 
          "embryos", 
          "tissue", 
          "factors", 
          "mechanism", 
          "mice", 
          "same factors", 
          "lines", 
          "culture", 
          "formation", 
          "morphology", 
          "capacity", 
          "tool", 
          "teratoma", 
          "data", 
          "skin biopsies", 
          "research", 
          "method", 
          "biopsy", 
          "research subjects", 
          "subjects"
        ], 
        "name": "Reprogramming of human somatic cells to pluripotency with defined factors", 
        "pagination": "141-146", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1011992920"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nature06534"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "18157115"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nature06534", 
          "https://app.dimensions.ai/details/publication/pub.1011992920"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:34", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_440.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nature06534"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nature06534'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nature06534'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nature06534'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nature06534'


     

    This table displays all metadata directly associated to this object as RDF triples.

    313 TRIPLES      21 PREDICATES      109 URIs      93 LITERALS      34 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nature06534 schema:about N046fbd537cd946919c40edac946ebe1a
    2 N0d06cfbbc3794d16a91a4b3bdd3ac4c1
    3 N1542b4b06c98435bbfc4ef56659b36d4
    4 N1f43c75302c049b991dc264051687db7
    5 N2428d7ca7ff940299904057b775dfed1
    6 N2b8604dc5c3142c0a5ca90aab036ac39
    7 N2ccd7920736646259631c28d5eee67ff
    8 N34977509a9b940c2b6e3d7da8e2fa530
    9 N3cfc208772ee48e9aca9b695277b492f
    10 N3ea26331caec4908bead7c9f5d82f1f3
    11 N41d42492ce5c4ca99d7af12f4bac0851
    12 N67e4c22d9f034dd8bd8804e2e347a620
    13 N7998ccbe601d473790ea4add690d0b32
    14 N98967efbe02049278afb0fbefa2c96e8
    15 N9b76ebb604e449d682f62dd57b1ac3d1
    16 Nb333a9a7914d4a8eb9bcc7c073e09475
    17 Nb8435093f403435cacf49bbcefdc2406
    18 Nbb338cf93ae44fb7ae6bf4ad47a827ae
    19 Nbed86ff0e95042f095a338d17c3bfd74
    20 Nbf7b11d3457a4af98495e546d045c40b
    21 Ncad71b2be2a447c282acbafd4c03e280
    22 Nd79ccf7c52834ced9291cccbf1779587
    23 Ne03b82b2fdeb46808c5f51b900845df7
    24 Ne341ff01d689496699754bdfa1e3632c
    25 Neefd7e4851894dc2b32eda13fb3bf9fe
    26 Nf32c95c80ade49e4a410839b48524e03
    27 Nf338cdb06daf4bcf831bbd0335c84f90
    28 anzsrc-for:06
    29 anzsrc-for:0604
    30 schema:author N4cb9bbb637c941598fab9aea5cc8585d
    31 schema:citation sg:pub.10.1038/22780
    32 sg:pub.10.1038/nature05934
    33 sg:pub.10.1038/nature05944
    34 sg:pub.10.1038/nbt1107-1211a
    35 sg:pub.10.1038/nbt1310
    36 sg:pub.10.1038/nbt1318
    37 sg:pub.10.1038/nbt1335
    38 sg:pub.10.1038/nbt788
    39 schema:datePublished 2007-12-23
    40 schema:datePublishedReg 2007-12-23
    41 schema:description Pluripotency pertains to the cells of early embryos that can generate all of the tissues in the organism. Embryonic stem cells are embryo-derived cell lines that retain pluripotency and represent invaluable tools for research into the mechanisms of tissue formation. Recently, murine fibroblasts have been reprogrammed directly to pluripotency by ectopic expression of four transcription factors (Oct4, Sox2, Klf4 and Myc) to yield induced pluripotent stem (iPS) cells. Using these same factors, we have derived iPS cells from fetal, neonatal and adult human primary cells, including dermal fibroblasts isolated from a skin biopsy of a healthy research subject. Human iPS cells resemble embryonic stem cells in morphology and gene expression and in the capacity to form teratomas in immune-deficient mice. These data demonstrate that defined factors can reprogramme human cells to pluripotency, and establish a method whereby patient-specific cells might be established in culture.
    42 schema:genre article
    43 schema:isAccessibleForFree false
    44 schema:isPartOf Nc6e12acb20184fa6a94eafe3887b36ba
    45 Ne07acd230ca94f4cb326111ebdca858b
    46 sg:journal.1018957
    47 schema:keywords biopsy
    48 capacity
    49 cell lines
    50 cells
    51 culture
    52 data
    53 defined factors
    54 dermal fibroblasts
    55 early embryos
    56 ectopic expression
    57 embryonic stem cells
    58 embryos
    59 expression
    60 factors
    61 fibroblasts
    62 formation
    63 gene expression
    64 healthy research subjects
    65 human cells
    66 human iPS cells
    67 human primary cells
    68 human somatic cells
    69 iPS cells
    70 immune-deficient mice
    71 induced pluripotent stem cells
    72 invaluable tool
    73 lines
    74 mechanism
    75 method
    76 mice
    77 morphology
    78 murine fibroblasts
    79 organisms
    80 patient-specific cells
    81 pluripotency
    82 pluripotent stem cells
    83 primary cells
    84 research
    85 research subjects
    86 same factors
    87 skin biopsies
    88 somatic cells
    89 stem cells
    90 subjects
    91 teratoma
    92 tissue
    93 tissue formation
    94 tool
    95 transcription factors
    96 schema:name Reprogramming of human somatic cells to pluripotency with defined factors
    97 schema:pagination 141-146
    98 schema:productId N28b2b69939e140adbdcfec9482a4593a
    99 N76bdd91ec5204118ba76e003a681330a
    100 Nf2659bcf4ef24ea3b711555d87c31ba2
    101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011992920
    102 https://doi.org/10.1038/nature06534
    103 schema:sdDatePublished 2022-10-01T06:34
    104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    105 schema:sdPublisher N8c045206fba845558d0b04efdc86a2e0
    106 schema:url https://doi.org/10.1038/nature06534
    107 sgo:license sg:explorer/license/
    108 sgo:sdDataset articles
    109 rdf:type schema:ScholarlyArticle
    110 N00e19ee13cfc4af79565bc00ec27c895 rdf:first sg:person.01326207001.66
    111 rdf:rest rdf:nil
    112 N046fbd537cd946919c40edac946ebe1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Teratoma
    114 rdf:type schema:DefinedTerm
    115 N0d06cfbbc3794d16a91a4b3bdd3ac4c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Proto-Oncogene Proteins c-myc
    117 rdf:type schema:DefinedTerm
    118 N1542b4b06c98435bbfc4ef56659b36d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name HMGB Proteins
    120 rdf:type schema:DefinedTerm
    121 N1f43c75302c049b991dc264051687db7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Transplantation, Heterologous
    123 rdf:type schema:DefinedTerm
    124 N20b8fbe5bcab4c2e93387b71da98c91b rdf:first sg:person.01165236266.47
    125 rdf:rest Nbad3869494024e2686fff1266624bc0d
    126 N2428d7ca7ff940299904057b775dfed1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Gene Expression Profiling
    128 rdf:type schema:DefinedTerm
    129 N24c89d37d16d40fe94bc6b1356c5f8a3 rdf:first sg:person.0701400066.39
    130 rdf:rest Nd5aafdb0eda34840aa0b7d612ec54474
    131 N28b2b69939e140adbdcfec9482a4593a schema:name doi
    132 schema:value 10.1038/nature06534
    133 rdf:type schema:PropertyValue
    134 N2b8604dc5c3142c0a5ca90aab036ac39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Fibroblasts
    136 rdf:type schema:DefinedTerm
    137 N2ccd7920736646259631c28d5eee67ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name SOXB1 Transcription Factors
    139 rdf:type schema:DefinedTerm
    140 N34977509a9b940c2b6e3d7da8e2fa530 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Kruppel-Like Factor 4
    142 rdf:type schema:DefinedTerm
    143 N3cfc208772ee48e9aca9b695277b492f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name DNA-Binding Proteins
    145 rdf:type schema:DefinedTerm
    146 N3ea26331caec4908bead7c9f5d82f1f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Pluripotent Stem Cells
    148 rdf:type schema:DefinedTerm
    149 N41d42492ce5c4ca99d7af12f4bac0851 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Promoter Regions, Genetic
    151 rdf:type schema:DefinedTerm
    152 N43c5dd8caa89479f83fc6aa40be66be2 rdf:first sg:person.01022207136.99
    153 rdf:rest N00e19ee13cfc4af79565bc00ec27c895
    154 N44631e2caddd4a53aafe62b5cb3bb671 rdf:first sg:person.01071737774.79
    155 rdf:rest N43c5dd8caa89479f83fc6aa40be66be2
    156 N4cb9bbb637c941598fab9aea5cc8585d rdf:first sg:person.0633264666.40
    157 rdf:rest N24c89d37d16d40fe94bc6b1356c5f8a3
    158 N67e4c22d9f034dd8bd8804e2e347a620 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name Octamer Transcription Factor-3
    160 rdf:type schema:DefinedTerm
    161 N76bdd91ec5204118ba76e003a681330a schema:name pubmed_id
    162 schema:value 18157115
    163 rdf:type schema:PropertyValue
    164 N7998ccbe601d473790ea4add690d0b32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Cell Differentiation
    166 rdf:type schema:DefinedTerm
    167 N8c045206fba845558d0b04efdc86a2e0 schema:name Springer Nature - SN SciGraph project
    168 rdf:type schema:Organization
    169 N98967efbe02049278afb0fbefa2c96e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    170 schema:name Fetus
    171 rdf:type schema:DefinedTerm
    172 N9b76ebb604e449d682f62dd57b1ac3d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name DNA Methylation
    174 rdf:type schema:DefinedTerm
    175 Na0d96dab27344d07a876d805095be314 rdf:first sg:person.01233401714.29
    176 rdf:rest N44631e2caddd4a53aafe62b5cb3bb671
    177 Nb333a9a7914d4a8eb9bcc7c073e09475 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    178 schema:name Infant, Newborn
    179 rdf:type schema:DefinedTerm
    180 Nb8435093f403435cacf49bbcefdc2406 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Transcription Factors
    182 rdf:type schema:DefinedTerm
    183 Nbad3869494024e2686fff1266624bc0d rdf:first sg:person.01206166374.49
    184 rdf:rest Na0d96dab27344d07a876d805095be314
    185 Nbb338cf93ae44fb7ae6bf4ad47a827ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    186 schema:name Kruppel-Like Transcription Factors
    187 rdf:type schema:DefinedTerm
    188 Nbed86ff0e95042f095a338d17c3bfd74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    189 schema:name Animals
    190 rdf:type schema:DefinedTerm
    191 Nbf7b11d3457a4af98495e546d045c40b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    192 schema:name Cells, Cultured
    193 rdf:type schema:DefinedTerm
    194 Nc6e12acb20184fa6a94eafe3887b36ba schema:volumeNumber 451
    195 rdf:type schema:PublicationVolume
    196 Ncad71b2be2a447c282acbafd4c03e280 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    197 schema:name Humans
    198 rdf:type schema:DefinedTerm
    199 Nd5aafdb0eda34840aa0b7d612ec54474 rdf:first sg:person.01300040514.16
    200 rdf:rest N20b8fbe5bcab4c2e93387b71da98c91b
    201 Nd79ccf7c52834ced9291cccbf1779587 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    202 schema:name Embryonic Stem Cells
    203 rdf:type schema:DefinedTerm
    204 Ne03b82b2fdeb46808c5f51b900845df7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    205 schema:name Adult
    206 rdf:type schema:DefinedTerm
    207 Ne07acd230ca94f4cb326111ebdca858b schema:issueNumber 7175
    208 rdf:type schema:PublicationIssue
    209 Ne341ff01d689496699754bdfa1e3632c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    210 schema:name Homeodomain Proteins
    211 rdf:type schema:DefinedTerm
    212 Neefd7e4851894dc2b32eda13fb3bf9fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    213 schema:name Nanog Homeobox Protein
    214 rdf:type schema:DefinedTerm
    215 Nf2659bcf4ef24ea3b711555d87c31ba2 schema:name dimensions_id
    216 schema:value pub.1011992920
    217 rdf:type schema:PropertyValue
    218 Nf32c95c80ade49e4a410839b48524e03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    219 schema:name Cell Shape
    220 rdf:type schema:DefinedTerm
    221 Nf338cdb06daf4bcf831bbd0335c84f90 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    222 schema:name Mice
    223 rdf:type schema:DefinedTerm
    224 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    225 schema:name Biological Sciences
    226 rdf:type schema:DefinedTerm
    227 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
    228 schema:name Genetics
    229 rdf:type schema:DefinedTerm
    230 sg:journal.1018957 schema:issn 0028-0836
    231 1476-4687
    232 schema:name Nature
    233 schema:publisher Springer Nature
    234 rdf:type schema:Periodical
    235 sg:person.01022207136.99 schema:affiliation grid-institutes:grid.38142.3c
    236 schema:familyName Lensch
    237 schema:givenName M. William
    238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022207136.99
    239 rdf:type schema:Person
    240 sg:person.01071737774.79 schema:affiliation grid-institutes:grid.2515.3
    241 schema:familyName Lerou
    242 schema:givenName Paul H.
    243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071737774.79
    244 rdf:type schema:Person
    245 sg:person.01165236266.47 schema:affiliation grid-institutes:grid.38142.3c
    246 schema:familyName Yabuuchi
    247 schema:givenName Akiko
    248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165236266.47
    249 rdf:type schema:Person
    250 sg:person.01206166374.49 schema:affiliation grid-institutes:grid.38142.3c
    251 schema:familyName Huo
    252 schema:givenName Hongguang
    253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206166374.49
    254 rdf:type schema:Person
    255 sg:person.01233401714.29 schema:affiliation grid-institutes:grid.62560.37
    256 schema:familyName Ince
    257 schema:givenName Tan A.
    258 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233401714.29
    259 rdf:type schema:Person
    260 sg:person.01300040514.16 schema:affiliation grid-institutes:grid.38142.3c
    261 schema:familyName West
    262 schema:givenName Jason A.
    263 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01300040514.16
    264 rdf:type schema:Person
    265 sg:person.01326207001.66 schema:affiliation grid-institutes:grid.38142.3c
    266 schema:familyName Daley
    267 schema:givenName George Q.
    268 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326207001.66
    269 rdf:type schema:Person
    270 sg:person.0633264666.40 schema:affiliation grid-institutes:grid.38142.3c
    271 schema:familyName Park
    272 schema:givenName In-Hyun
    273 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633264666.40
    274 rdf:type schema:Person
    275 sg:person.0701400066.39 schema:affiliation grid-institutes:grid.38142.3c
    276 schema:familyName Zhao
    277 schema:givenName Rui
    278 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701400066.39
    279 rdf:type schema:Person
    280 sg:pub.10.1038/22780 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021312708
    281 https://doi.org/10.1038/22780
    282 rdf:type schema:CreativeWork
    283 sg:pub.10.1038/nature05934 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002347899
    284 https://doi.org/10.1038/nature05934
    285 rdf:type schema:CreativeWork
    286 sg:pub.10.1038/nature05944 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019109862
    287 https://doi.org/10.1038/nature05944
    288 rdf:type schema:CreativeWork
    289 sg:pub.10.1038/nbt1107-1211a schema:sameAs https://app.dimensions.ai/details/publication/pub.1003688019
    290 https://doi.org/10.1038/nbt1107-1211a
    291 rdf:type schema:CreativeWork
    292 sg:pub.10.1038/nbt1310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024578139
    293 https://doi.org/10.1038/nbt1310
    294 rdf:type schema:CreativeWork
    295 sg:pub.10.1038/nbt1318 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033397919
    296 https://doi.org/10.1038/nbt1318
    297 rdf:type schema:CreativeWork
    298 sg:pub.10.1038/nbt1335 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049953935
    299 https://doi.org/10.1038/nbt1335
    300 rdf:type schema:CreativeWork
    301 sg:pub.10.1038/nbt788 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013128911
    302 https://doi.org/10.1038/nbt788
    303 rdf:type schema:CreativeWork
    304 grid-institutes:grid.2515.3 schema:alternateName Division of Newborn Medicine, Brigham & Women’s Hospital and Children’s Hospital Boston, Boston, Massachusetts 02115, USA
    305 schema:name Division of Newborn Medicine, Brigham & Women’s Hospital and Children’s Hospital Boston, Boston, Massachusetts 02115, USA
    306 rdf:type schema:Organization
    307 grid-institutes:grid.38142.3c schema:alternateName Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School
    308 schema:name Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School
    309 Division of Pediatric Hematology/Oncology, Children’s Hospital Boston and Dana Farber Cancer Institute; Division of Hematology, Brigham & Women’s Hospital, Boston, Massachusetts 02115, USA; and Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA
    310 rdf:type schema:Organization
    311 grid-institutes:grid.62560.37 schema:alternateName Department of Pathology, Brigham and Women’s Hospital, and
    312 schema:name Department of Pathology, Brigham and Women’s Hospital, and
    313 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...